Imugene tweeted about Dr Bilal Shah delivering an encore presentation at the iwCAR-T 2024 meeting in Florida, on 'Updates for Allo CAR-T PBCAR0191: Bijal Shah'.
What is also interesting is that 2 members of our Scientific Advosry Board also presented at this conference. So Imugene definitely has some firepower in the CAR-T space.
Under CAR-T advances in Lung cancer:
- Tumor immune modulation in solid tumor CAR T-cell therapy: Prasad Adusumilli.
Under Genitourinary cancers.
- Advancing engineered T-cell therapies for solid tumors: Saul Priceman
GLTAH
Imugene tweeted about Dr Bilal Shah delivering an encore...
-
- There are more pages in this discussion • 1,719 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.6¢ | $1.037M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1882949 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 399643 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |